Daniela Braconi

Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment

L. Ranganath, Anna M. Milan, Andrew T. Hughes et al. · Annals of the Rheumatic Diseases · 2014 · 157 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial

L. Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux et al. · The Lancet Diabetes & Endocrinology · 2020 · 123 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +3

Alkaptonuria is a novel human secondary amyloidogenic disease

Lia Millucci, Adriano Spreafico, Laura Tinti et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2012 · 76 citations · Full text

Medicine, Biochemistry, Pathology +9

Proteomic and redox‐proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes

Daniela Braconi, Marcella Laschi, Adam Taylor et al. · Journal of Cellular Biochemistry · 2010 · 57 citations

Life Sciences, Biochemistry, Cell Biology +17

Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: Implications in alkaptonuria

Marcella Laschi, Laura Tinti, Daniela Braconi et al. · Journal of Cellular Physiology · 2011 · 54 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9